Liquid chromatography/negative ion electrospray tandem mass spectrometry method for the quantification of rosuvastatin in human plasma: Application to a pharmacokinetic study

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 856, Issue 1-2, 2007, Pages 35-40

  Gao, Jun ^a,b   Zhong, Dafang ^a   Duan, Xiaotao ^a,b   Chen, Xiaoyan ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

LC MS MS; Pharmacokinetics; Rosuvastatin

Indexed keywords

AMMONIA; ELECTROSPRAY IONIZATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PLASMA (HUMAN);

AQUEOUS AMMONIA; CHROMATOGRAPHIC SEPARATION; ROSUVASTATIN;

PROTEINS;

AMMONIA; ETHER; HYDROCHLOROTHIAZIDE; METHANOL; ROSUVASTATIN; WATER;

ACCURACY; ANALYTICAL EQUIPMENT; ANALYTICAL ERROR; AQUEOUS SOLUTION; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; DRUG ISOLATION; DRUG STABILITY; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; HUMAN EXPERIMENT; INTERMETHOD COMPARISON; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; MAXIMUM PLASMA CONCENTRATION; NEGATIVE ION ELECTROSPRAY; NORMAL HUMAN; PLASMA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; SINGLE DRUG DOSE; STANDARD; TANDEM MASS SPECTROMETRY; TIME TO MAXIMUM PLASMA CONCENTRATION; VALIDATION PROCESS; VOLUNTEER;

ADMINISTRATION, ORAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOROBENZENES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PYRIMIDINES; REFERENCE STANDARDS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SULFONAMIDES;

EID: 34548129560     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2007.05.012     Document Type: Article

References (17)

1. Chapman M.J., and McTaggart F. Atheroscler. Suppl. 2 (2002) 33
2. Nezasa K., Higaki K., Matsumura T., Inazawa K., Hasegawa H., Nakano M., and Koike M. Drug Metab. Dispos. 30 (2002) 1158
3. Olsson A.G., Pears J., McKellar J., Mizan J., and Raza A. Am. J. Cardiol. 88 (2001) 504
4. Bullano M.F., Wertz D.A., Yang G.W., Kamat S., Borok G.M., Gandhi S., McDonough K.L., and Willey V.J. Pharmacotherapy 26 (2006) 469
5. Martin P.D., Warwick M.J., Dane A.L., and Cantarini M.V. Clin. Ther. 25 (2003) 2215
6. Martin P.D., Dane A.L., Nwose O.M., Schneck D.W., and Warwick M.J. J. Clin. Pharmacol. 42 (2002) 1116
7. Lee E., Ryan E., Birmingham B., Zalikowski J., March R., Ambrose H., Moore R., Lee C., Chen Y., and Schneck D. Clin. Pharmacol. Ther. 78 (2005) 330
8. Olsson A.G., Istad H., Luurila O., Ose L., Stender S., Tuomilehto J., Wiklund O., Southworth H., Pears J., and Wilpshaar J.W. Am. Heart J. 144 (2002) 1044
9. Kumar T.R., Shitut N.R., Kumar P.K., Vinu M.C., Kumar V.V., Mullangi R., and Srinivas N.R. Biomed. Chromatogr. 20 (2006) 881
10. Vittal S., Shitut N.R., Kumar T.R., Vinu M.C., Mullangi R., and Srinivas N.R. Biomed. Chromatogr. 20 (2006) 1252
11. Hull C.K., Penman A.D., Smith C.K., and Martin P.D. J. Chromatogr. B 772 (2002) 219
12. Oudhoff K.A., Sangster T., Thomas E., and Wilson I.D. J. Chromatogr. B 832 (2006) 191
13. Trivedi R.K., Kallem R.R., Mullangi R., and Srinivas N.R. J. Pharm. Biomed. Anal. 39 (2005) 661
14. Xu D.H., Ruan Z.H., Zhou Q., Yuan H., and Jiang B. Rapid Commun. Mass Spectrom. 20 (2006) 2369
15. Nirogi R.V.S., Kandikere V.N., Shrivastava W., Mudigonda K., and Datla P.V. Rapid Commun. Mass Spectrom. 20 (2006) 1225
16. Shah V.P., Midha K.K., Findlay J.W., Hulse J.D., Mcgliveray I.J., McKay G., Miller K.J., Patnaik R.N., Powell M.I., Tonelli A., and Viswanathan C.T. J. Pharm. Sci. 17 (2000) 1511
17. Martin P.D., Mitchell P.D., and Schneck D.W. Br. J. Clin. Pharmacol. 54 (2002) 472